158 related articles for article (PubMed ID: 24266618)
21. The effect of NNRTIs on HIV reverse transcriptase dimerization.
Tachedjian G; Goff SP
Curr Opin Investig Drugs; 2003 Aug; 4(8):966-73. PubMed ID: 14508881
[TBL] [Abstract][Full Text] [Related]
22. Docking and quantitative structure-activity relationship studies for the bisphenylbenzimidazole family of non-nucleoside inhibitors of HIV-1 reverse transcriptase.
Lagos CF; Caballero J; Gonzalez-Nilo FD; David Pessoa-Mahana C; Perez-Acle T
Chem Biol Drug Des; 2008 Nov; 72(5):360-9. PubMed ID: 19012572
[TBL] [Abstract][Full Text] [Related]
23. Novel pyridinone derivatives as non-nucleoside reverse transcriptase inhibitors (NNRTIs) with high potency against NNRTI-resistant HIV-1 strains.
Li A; Ouyang Y; Wang Z; Cao Y; Liu X; Ran L; Li C; Li L; Zhang L; Qiao K; Xu W; Huang Y; Zhang Z; Tian C; Liu Z; Jiang S; Shao Y; Du Y; Ma L; Wang X; Liu J
J Med Chem; 2013 May; 56(9):3593-608. PubMed ID: 23540737
[TBL] [Abstract][Full Text] [Related]
24. Combined approach using ligand efficiency, cross-docking, and antitarget hits for wild-type and drug-resistant Y181C HIV-1 reverse transcriptase.
García-Sosa AT; Sild S; Takkis K; Maran U
J Chem Inf Model; 2011 Oct; 51(10):2595-611. PubMed ID: 21875140
[TBL] [Abstract][Full Text] [Related]
25. Rational approaches for the design of effective human immunodeficiency virus type 1 nonnucleoside reverse transcriptase inhibitors.
Ribone SR; Quevedo MA; Madrid M; Briñón MC
J Chem Inf Model; 2011 Jan; 51(1):130-8. PubMed ID: 21133347
[TBL] [Abstract][Full Text] [Related]
26. Flexible docking of pyridinone derivatives into the non-nucleoside inhibitor binding site of HIV-1 reverse transcriptase.
Medina-Franco JL; Rodríguez-Morales S; Juárez-Gordiano C; Hernández-Campos A; Jiménez-Barbero J; Castillo R
Bioorg Med Chem; 2004 Dec; 12(23):6085-95. PubMed ID: 15519154
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis and biological evaluation of 3-benzyloxy-linked pyrimidinylphenylamine derivatives as potent HIV-1 NNRTIs.
Rai D; Chen W; Tian Y; Chen X; Zhan P; De Clercq E; Pannecouque C; Balzarini J; Liu X
Bioorg Med Chem; 2013 Dec; 21(23):7398-405. PubMed ID: 24134904
[TBL] [Abstract][Full Text] [Related]
28. Computer-aided molecular design of highly potent HIV-1 RT inhibitors: 3D QSAR and molecular docking studies of efavirenz derivatives.
Pungpo P; Saparpakorn P; Wolschann P; Hannongbua S
SAR QSAR Environ Res; 2006 Aug; 17(4):353-70. PubMed ID: 16920659
[TBL] [Abstract][Full Text] [Related]
29. Exploring isoxazole and carboxamide derivatives as potential non-nucleoside reverse transcriptase inhibitors.
Kurup SS; Joshi KA
J Mol Graph Model; 2016 Apr; 65():113-28. PubMed ID: 26973048
[TBL] [Abstract][Full Text] [Related]
30. Triazole derivatives as non-nucleoside inhibitors of HIV-1 reverse transcriptase--structure-activity relationships and crystallographic analysis.
Kirschberg TA; Balakrishnan M; Huang W; Hluhanich R; Kutty N; Liclican AC; McColl DJ; Squires NH; Lansdon EB
Bioorg Med Chem Lett; 2008 Feb; 18(3):1131-4. PubMed ID: 18083512
[TBL] [Abstract][Full Text] [Related]
31. Deconstruction of non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus type 1 for exploration of the optimization landscape of fragments.
Brandt P; Geitmann M; Danielson UH
J Med Chem; 2011 Feb; 54(3):709-18. PubMed ID: 21207958
[TBL] [Abstract][Full Text] [Related]
32. Diphenyl ether non-nucleoside reverse transcriptase inhibitors with excellent potency against resistant mutant viruses and promising pharmacokinetic properties.
Sweeney ZK; Kennedy-Smith JJ; Wu J; Arora N; Billedeau JR; Davidson JP; Fretland J; Hang JQ; Heilek GM; Harris SF; Hirschfeld D; Inbar P; Javanbakht H; Jernelius JA; Jin Q; Li Y; Liang W; Roetz R; Sarma K; Smith M; Stefanidis D; Su G; Suh JM; Villaseñor AG; Welch M; Zhang FJ; Klumpp K
ChemMedChem; 2009 Jan; 4(1):88-99. PubMed ID: 19006142
[TBL] [Abstract][Full Text] [Related]
33. Inhibition activities of catechol diether based non-nucleoside inhibitors against the HIV reverse transcriptase variants: Insights from molecular docking and ONIOM calculations.
Samanta PN; Das KK
J Mol Graph Model; 2017 Aug; 75():294-305. PubMed ID: 28623781
[TBL] [Abstract][Full Text] [Related]
34. [The application of structural optimization strategies in drug design of HIV NNRTIs].
Wang L; Zhan P; Liu XY
Yao Xue Xue Bao; 2012 Nov; 47(11):1409-22. PubMed ID: 23387070
[TBL] [Abstract][Full Text] [Related]
35. The HIV-1 non-nucleoside reverse transcriptase inhibitors (part V): capravirine and its analogues.
Li X; Zhan P; De Clercq E; Liu X
Curr Med Chem; 2012; 19(36):6138-49. PubMed ID: 22934811
[TBL] [Abstract][Full Text] [Related]
36. A detailed comparison of current docking and scoring methods on systems of pharmaceutical relevance.
Perola E; Walters WP; Charifson PS
Proteins; 2004 Aug; 56(2):235-49. PubMed ID: 15211508
[TBL] [Abstract][Full Text] [Related]
37. Design, synthesis and biological evaluation of N2,N4-disubstituted-1,1,3-trioxo-2H,4H-pyrrolo[1,2-b][1,2,4,6]thiatriazine derivatives as HIV-1 NNRTIs.
Chen W; Zhan P; De Clercq E; Pannecouque C; Balzarini J; Jiang X; Liu X
Bioorg Med Chem; 2013 Nov; 21(22):7091-100. PubMed ID: 24119448
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and biological evaluation of pyridinone analogues as novel potent HIV-1 NNRTIs.
Cao Y; Zhang Y; Wu S; Yang Q; Sun X; Zhao J; Pei F; Guo Y; Tian C; Zhang Z; Wang H; Ma L; Liu J; Wang X
Bioorg Med Chem; 2015 Jan; 23(1):149-59. PubMed ID: 25468035
[TBL] [Abstract][Full Text] [Related]
39. Search for non-nucleoside inhibitors of HIV-1 reverse transcriptase using chemical similarity, molecular docking, and MM-GB/SA scoring.
Barreiro G; Guimarães CR; Tubert-Brohman I; Lyons TM; Tirado-Rives J; Jorgensen WL
J Chem Inf Model; 2007; 47(6):2416-28. PubMed ID: 17949071
[TBL] [Abstract][Full Text] [Related]
40. Classification and regression trees--studies of HIV reverse transcriptase inhibitors.
Daszykowski M; Walczak B; Xu QS; Daeyaert F; de Jonge MR; Heeres J; Koymans LM; Lewi PJ; Vinkers HM; Janssen PA; Massart DL
J Chem Inf Comput Sci; 2004; 44(2):716-26. PubMed ID: 15032554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
